| Cat.No.: | BSM-0081 |
| CAS No.: | 1869912-40-2 |
| Figure: |
|
| Synonyms: | 4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]-1,3-dimethylpiperazin-2-one, 6-hydroxynaphthalene-2-carboxylic acid |
| Description: | AZD-5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor with a bivalent binding mode. AZD-5153 ligates two bromodomains in BRD4 simultaneously. Displays cellular and antitumor activity in preclinical hematologic tumor models. |
| Appearance: | Crystalline solid |
| Molecular Weight: | 667.8 |
| Purity: | ≥98% by HPLC |
| Storage: | -20°C |
| Targets: | BET/BRD4 bromodomain |
| Molecular Formula: | C₂₅H₃₃N₇O₃ ∙C₁₁H₈O₃ |
| MDL Number: | MFCD10687152 |
| Solubility: | DMSO |
| Shipping Conditions: | Gel Pack |
| Warning: | For Research Use Only! Not For Use in Humans. |
| Product Types | ||
| ◆ Synthetic Peptides | ||
| SP-0001 | Bromodomain Non-Acetylated Ligand 4 | Inquiry |
| SP-0002 | Bromodomain Non-Acetylated Ligand 3 | Inquiry |
| SP-0003 | Bromodomain Non-Acetylated Ligand 1 | Inquiry |
| SP-0004 | Bromodomain Ligand 3 | Inquiry |
| SP-0005 | BET Bromodomain Ligand | Inquiry |
| Related Gene / Proteins | |||
| BET | BRCA1 | BRCA2 | BRCC3 |
| BRD | brd1 | brd2 | brd3 |
| brd4 | BRD7 | BRD8 | brd9 |
| brdt | BRL | BRM | BRMS1 |
| BRPF1 | BRPF2 | brpf3 | BRWD1 More > |
| BRWD3 | |||
USA
Quick Links
Easy access to products and services you need from our library via powerful searching tools
